Skip to content

Clinical significance of the Mini Nutritional Assessment-Short Form (MNA-SF) in patients with lung cancer

Clinical significance of the Mini Nutritional Assessment-Short Form (MNA-SF) in patients with lung cancer - Clinical significance of the Mini Nutritional Assessment-Short Form (MNA-SF) in patients with lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000061902
Enrollment
60
Registered
2026-06-16
Start date
2025-06-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

None listed

Sponsors

Seirei Hamamatsu General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with stage IV non-small cell lung cancer (NSCLC) hospitalized between January 1, 2022, and December 31, 2023.

Exclusion criteria

Exclusion criteria: Patients under the age of 18

Design outcomes

Primary

MeasureTime frame
The primary endpoint was the asociation between MNA-SF category and overall survival (OS).

Countries

Japan

Contacts

Public ContactChinatsu Nakane

Seirei Hamamatsu General Hospital Department of Respiratory Medicine

c-nakane@sis.seirei.or.jp053-474-2222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026